BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37924729)

  • 1. Data-driven analysis on the performance evaluation of national R&D projects in Korea.
    Cho H; Ahn H; Park E
    Eval Program Plann; 2024 Feb; 102():102383. PubMed ID: 37924729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International R&D Collaboration for a Global Aging Society: Focusing on Aging-Related National-Funded Projects.
    Lee D; Kim S; Kim K
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33217997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural equation model for the evaluation of national funding on R&D project of SMEs in consideration with MBNQA criteria.
    Sohn SY; Gyu Joo Y; Kyu Han H
    Eval Program Plann; 2007 Feb; 30(1):10-20. PubMed ID: 17689310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of R&D collaborations and non-patent IP policies in government technology transfer performance: Evidence from U.S. federal agencies (1999-2016).
    Hemmatian I; Ponzio TA; Joshi AM
    PLoS One; 2022; 17(5):e0268828. PubMed ID: 35609062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments.
    Han E; Kim TH; Jeung MJ; Lee EK
    Clin Ther; 2013 Jul; 35(7):941-9. PubMed ID: 23806327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public R&D Projects-Based Investment and Collaboration Framework for an Overarching South Korean National Strategy of Personalized Medicine.
    Lee D; Kim K
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the efficiency of small and medium-sized enterprises of a national technology innovation research and development program.
    Park S
    Springerplus; 2014; 3():403. PubMed ID: 25120949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of SMEs' R&D performances by machine learning for project selection.
    Yoo HS; Jung YL; Jun SP
    Sci Rep; 2023 May; 13(1):7598. PubMed ID: 37165080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an evaluation framework for publicly funded R&D projects: The case of Korea's Next Generation Network.
    Kim E; Kim S; Kim H
    Eval Program Plann; 2017 Aug; 63():18-28. PubMed ID: 28319783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of technology convergence networks in Korea: Characteristics of temporal changes in R&D according to institution type.
    Choi JY; Jeong S; Jung JK
    PLoS One; 2018; 13(2):e0192195. PubMed ID: 29420574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on cancer diagnosis in Malaysia: current status.
    Looi LM; Zubaidah Z; Cheah PL; Cheong SK; Gudum HR; Iekhsan O; Ikram SI; Jamal R; Mak JW; Othman NH; Puteri JN; Rosline H; Sabariah AR; Seow HF; Sharifah NA;
    Malays J Pathol; 2004 Jun; 26(1):13-27. PubMed ID: 16190103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in technology innovation R&D performance creation behavior between for-profit institutions and not-for-profit institutions.
    Park S
    Springerplus; 2016; 5():451. PubMed ID: 27119055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in methodological research: perspectives from researchers and commissioners.
    Lilford RJ; Richardson A; Stevens A; Fitzpatrick R; Edwards S; Rock F; Hutton JL
    Health Technol Assess; 2001; 5(8):1-57. PubMed ID: 11368832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effectiveness of coupon-mediated newborn hearing screening program through comparison of two government-funded pilot projects in South Korea.
    Park SK; Chang J; Chung YS; Oh SH
    Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110256. PubMed ID: 32738621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family planning operations research in Africa: reviewing a decade of experience.
    Wawer MJ; McNamara R; McGinn T; Lauro D
    Stud Fam Plann; 1991; 22(5):279-93. PubMed ID: 1759274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of trends in patent development for coronavirus detection, prevention, and treatment technologies in key countries.
    Wei F; Zhou H; Gao G; Zheng Q
    J Biosaf Biosecur; 2022 Jun; 4(1):23-32. PubMed ID: 34746687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research.
    Jung YL; Yoo HS; Kim ES
    Health Res Policy Syst; 2019 Dec; 17(1):103. PubMed ID: 31870382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.